Elizabeth Ann Beierle

19PUBLICATIONS
42CO-AUTHORS
Radiation therapyPredictive and prognostic markersNeurology and neuromuscular diseasesHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 15, 2026
Strategies to Improve Sensitivity to Radiotherapy in Pediatric Solid Tumors.

|Feb 26, 2026
Upregulation of the lncRNA MEG3 in Metastatic Hepatoblastoma.

Morgan L Brown, Maryam G Shaikh, Nazia Nazam

|Jan 15, 2026
PP2A activation targets MYCN in neuroblastoma.

Nazia Nazam, Shamza Manzoor, Maryam Shaikh

|May 14, 2025
A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29.

Swatika Butey, Morgan L Brown, Janet R Julson

|Nov 27, 2024
Novel PP2A-Activating Compounds in Neuroblastoma.

Nazia Nazam, Laura V Bownes, Janet R Julson

|Aug 29, 2024
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.

Amber B Jones, Kaysaw Tuy, Cyntanna C Hawkins

Pageof 4

Frequent Collaborators

10 joint publications

Colin H Quinn

8 joint publications

Raoud Marayati

4 joint publications

Laura V Bownes

4 joint publications

Janet Rae Julson